武漢艾必賽生物有限公司推薦Anti-Hendra virus/HeV Glycoprotein G Monoclonal Antibody (1A207)，精品抗體
鏈接：https://www.abinscience.cn/product/34/8923.html
名稱：Anti-Hendra virus/HeV Glycoprotein G Monoclonal Antibody (1A207)抗體
別名：Glycoprotein G, G, Hendra virus (isolate Horse/Autralia/Hendra/1994) (HeV)
貨號(hào)：VK685035
適用物種：Hendra virus (isolate Horse/Autralia/Hendra/1994) (HeV)
宿主：Mouse
形式：Liquid
純度：>95%
同種型：IgG1
應(yīng)用：ELISA, WB
純化：Protein G purified from mice ascites.
UniProt：O89343
用途范圍：僅用于科研
儲(chǔ)存：Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
產(chǎn)品介紹：Anti-Hendra virus/HeV Glycoprotein G Monoclonal Antibody 是一種單克隆抗體，由能夠特異識(shí)別 Hendra virus/HeV Glycoprotein G 的抗原結(jié)合片段（Fab）與 human IgG1 的 Fc 片段融合而成。這種抗體結(jié)構(gòu)使其能夠精準(zhǔn)靶向 Hendra virus/HeV Glycoprotein G，便于在科研和臨床應(yīng)用中進(jìn)行病毒的檢測(cè)、定位以及相關(guān)的免疫學(xué)研究等。abinscience產(chǎn)品具有親和力高，靈敏度高，特異性好，穩(wěn)定性強(qiáng)等優(yōu)勢(shì)。
產(chǎn)品購(gòu)買聯(lián)系方式：027-87433958/18162686757
郵箱：info@abinscience.com
參考文獻(xiàn)：
Architecture and antigenicity of the Nipah virus attachment glycoprotein. PMID: 35239409
Potent monoclonal antibody-mediated neutralization of a divergent Hendra virus variant. PMID: 35617431
A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses. PMID: 37243163
Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody. PMID: 24130486
An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections. PMID: 31570878
Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F protein. PMID: 36932063
Development and laboratory evaluation of a competitive ELISA for serodiagnosis of Nipah and Hendra virus infection using recombinant Nipah glycoproteins and a monoclonal antibody. PMID: 36816187
A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection. PMID: 31686101
Construction of the safe neutralizing assay system using pseudotyped Nipah virus and G protein-specific monoclonal antibody. PMID: 30995971
Identification of Hendra virus G glycoprotein residues that are critical for receptor binding. PMID: 17376907
Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor binding. PMID: 18799571
Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins. PMID: 33927387
Prefusion stabilization of the Hendra and Langya virus F proteins. PMID: 38214525
Structure and design of Langya virus glycoprotein antigens. PMID: 38593070
Location of, immunogenicity of and relationships between neutralization epitopes on the attachment protein (G) of Hendra virus. PMID: 16186240
Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses. PMID: 19216624
Vaccines to Emerging Viruses: Nipah and Hendra. PMID: 32991264
Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies. PMID: 16378991
Evidence of a potential receptor-binding site on the Nipah virus G protein (NiV-G): identification of globular head residues with a role in fusion promotion and their localization on an NiV-G structural model. PMID: 16840334
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates. PMID: 38569014
Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. PMID: 18271743
Functional studies of host-specific ephrin-B ligands as Henipavirus receptors. PMID: 18054977
Prediction of the binding interface between monoclonal antibody m102.4 and Nipah attachment glycoprotein using structure-guided alanine scanning and computational docking. PMID: 33106487
Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems. PMID: 17292974
Biochemical, conformational, and immunogenic analysis of soluble trimeric forms of henipavirus fusion glycoproteins. PMID: 22915804
詳情請(qǐng)咨詢 abinScience 亞洲區(qū)官方子公司 —— 武漢艾必賽生物技術(shù)有限公司
官方網(wǎng)址：https://www.abinscience.cn
武漢艾必賽生物技術(shù)有限公司成立于 2023 年，是 abinScience 在亞洲地區(qū)設(shè)立的官方全資子公司，全面負(fù)責(zé) abinScience 品牌在亞太市場(chǎng)的科研試劑推廣、銷售及技術(shù)支持工作。
依托嚴(yán)格的產(chǎn)品研發(fā)體系和國(guó)際化的質(zhì)量管理標(biāo)準(zhǔn)，武漢艾必賽與 AtaGenix、ProteoGenix 等知名品牌保持長(zhǎng)期戰(zhàn)略合作，現(xiàn)已構(gòu)建起涵蓋抗體、重組蛋白、工具酶、試劑盒、實(shí)驗(yàn)耗材在內(nèi)的多品類供應(yīng)體系，面向區(qū)域內(nèi)科研機(jī)構(gòu)、高校實(shí)驗(yàn)室與生物醫(yī)藥企業(yè)，提供穩(wěn)定、高效、可信賴的產(chǎn)品與服務(wù)。
核心業(yè)務(wù)覆蓋：
? 抗體產(chǎn)品（單抗、多抗、重組抗體等）
? 蛋白與多肽試劑（標(biāo)簽蛋白、功能蛋白等）
? 分子與細(xì)胞實(shí)驗(yàn)相關(guān)耗材
? 定制化研發(fā)服務(wù)（蛋白表達(dá)、抗體定制、親和力成熟等）
? 科研供應(yīng)鏈整合與項(xiàng)目配套支持
武漢艾必賽始終秉持“Empowering Bioscience Discovery”的理念，為亞太地區(qū)的生命科學(xué)研究持續(xù)注入高質(zhì)量動(dòng)能。
